<DOC>
	<DOC>NCT01824381</DOC>
	<brief_summary>The purpose of this study is to analyze the security application of the amniotic membrane in extensive wounds in the granulation phase.</brief_summary>
	<brief_title>Use of the Amniotic Membrane in Large Wound Epithelialization</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<criteria>Acute wounds in granulation phase with a minimum area of 100 cm2. Patients 18 or more years. Patients offering sufficient guarantees of adherence to protocol. Sign the written informed consent. Meet all inclusion criteria. Patients with symptomatic chronic arterial insufficiency. Patients who are pregnant Patients in active lactation Patients physically fertile, defined as all women physiologically capable of becoming pregnant, including women whose career, lifestyle or sexual orientation precludes intercourse with a man and women whose partners have been sterilized by vasectomy or other methods, UNLESS they are using reliable contraception. This method of contraception can be: Complete abstinence from sexual intercourse Surgical sterilization (tubal ligation) Surgical sterilization of the partner (vasectomy) Implanted or injectable hormonal contraceptives, oral * Because hormonal contraceptives have a risk of thrombosis, should consider other methods of birth control. These reliable contraception must be maintained during their participation in the study. Patients with heart, kidney, liver, systemic immune may influence the survival of the patient during the test. Participation in other clinical trials. Inability to understand informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>extensive wounds</keyword>
	<keyword>amniotic membrane</keyword>
	<keyword>healing</keyword>
	<keyword>patients</keyword>
	<keyword>phase granulation</keyword>
</DOC>